Vivos Therapeutics, Inc. (VVOS) has 5 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 18, 2026 filed Sept. 14, 2026 | SOKOLOW LEONARD J Director | $0 | 12,000 | 0% | No | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 14, 2026 | JOHNSON GREGG C Director | $0 | 12,000 | 0% | No | |
|
|
||||||
| Sept. 18, 2026 filed June 30, 2026 | Huntsman Ronald Kirk Chief Executive Officer | $99,999 | 171,820 | New | No | |
|
|
||||||
| Aug. 26, 2026 filed July 31, 2026 | Amman Bradford K. Principal Accounting Officer | $164,000 | 400,000 | +327% | No | |
|
|
||||||
| July 15, 2026 filed June 30, 2026 | Skaff Michael C 10% Owner | $3,200,220 | 5,498,660 | 0% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free